Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MCTS1 anticorps (AA 1-181)

MCTS1 Reactivité: Humain ELISA, IHC, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7158949
  • Antigène Voir toutes MCTS1 Anticorps
    MCTS1 (Malignant T Cell Amplified Sequence 1 (MCTS1))
    Épitope
    • 16
    • 7
    • 7
    • 7
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-181
    Reactivité
    • 49
    • 13
    • 11
    • 7
    • 7
    • 6
    • 6
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 48
    • 2
    • 1
    Lapin
    Clonalité
    • 49
    • 2
    Polyclonal
    Conjugué
    • 28
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp MCTS1 est non-conjugé
    Application
    • 44
    • 18
    • 15
    • 14
    • 13
    • 7
    • 6
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Malignant T-cell-amplified sequence 1 protein (1-181AA)
    Isotype
    IgG
    Top Product
    Discover our top product MCTS1 Anticorps primaire
  • Indications d'application
    Recommended dilution: IHC:1:20-1:200, IF:1:200-1:500,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    MCTS1 (Malignant T Cell Amplified Sequence 1 (MCTS1))
    Autre désignation
    MCTS1 (MCTS1 Produits)
    Synonymes
    anticorps MCT-1, anticorps MCT1, anticorps MCT1a, anticorps cb517, anticorps zgc:55682, anticorps 1500019M23Rik, anticorps zgc:56242, anticorps mcts1, anticorps MGC89874, anticorps MCTS1, anticorps MCT-1A, anticorps mct-1, anticorps mct1, anticorps MCT-1B, anticorps mcts1-a, anticorps mcts1-b, anticorps MCTS1, re-initiation and release factor, anticorps solute carrier family 16 (monocarboxylate transporter), member 1b, anticorps malignant T cell amplified sequence 1, anticorps malignant T-cell amplified sequence 1, anticorps solute carrier family 16 member 1, anticorps malignant T-cell amplified sequence 1 S homeolog, anticorps monocarboxylate transporter 1, anticorps malignant T-cell amplified sequence 1 L homeolog, anticorps MCTS1, anticorps slc16a1b, anticorps Mcts1, anticorps mcts1, anticorps SLC16A1, anticorps mcts1.S, anticorps MCT1, anticorps mcts1.L
    Sujet

    Background: Anti-oncogene that play a role in cell cycle regulation, decreases cell doubling time and anchorage-dependent growth, shortens the duration of G1 transit time and G1/S transition. When constituvely expressed, increases CDK4 and CDK6 kinases activity and CCND1/cyclin D1 protein level, as well as G1 cyclin/CDK complex formation. Involved in translation initiation, promotes recruitment of aminoacetyled initiator tRNA to P site of 40S ribosomes. Can promote release of deacylated tRNA and mRNA from recycled 40S subunits following ABCE1-mediated dissociation of post-termination ribosomal complexes into subunits. Plays a role as translation enhancer, recruits the density-regulated protein/DENR and binds to the cap complex of the 5\'-terminus of mRNAs, subsequently altering the mRNA translation profile, up-regulates protein levels of BCL2L2, TFDP1, MRE11A, CCND1 and E2F1, while mRNA levels remains constant. Hyperactivates DNA damage signaling pathway, increased gamma-irradiation-induced phosphorylation of histone H2AX, and induces damage foci formation. Increases the overall number of chromosomal abnormalities such as larger chromosomes formation and multiples chromosomal fusions when overexpressed in gamma-irradiated cells. May play a role in promoting lymphoid tumor development: lymphoid cell lines overexpressing MCTS1 exhibit increased growth rates and display increased protection against apoptosis. May contribute to the pathogenesis and progression of breast cancer via promotion of angiogenesis through the decline of inhibitory THBS1/thrombospondin-1, and inhibition of apoptosis. Involved in the process of proteasome degradation to down-regulate Tumor suppressor p53/TP53 in breast cancer cell, Positively regulates phosphorylation of MAPK1 and MAPK3. Involved in translation initiation, promotes aminoacetyled initiator tRNA to P site of 40S ribosomes. Can promote release of deacylated tRNA and mRNA from recycled 40S subunits following ABCE1-mediated dissociation of post-termination ribosomal complexes into subunits.

    Aliases: FLJ39637 antibody, Malignant T cell amplified sequence 1 antibody, Malignant T cell-amplified sequence 1 antibody, MCT 1 antibody, MCT-1 antibody, MCT1 antibody, MCTS 1 antibody, MCTS1 antibody, MCTS1_HUMAN antibody, Multiple copies T cell malignancies 1 antibody, Multiple copies T cell malignancies antibody, Multiple copies T-cell malignancies antibody, Oncogene MCT 1 antibody, Oncogene MCT1 antibody

    UniProt
    Q9ULC4
Vous êtes ici: